Dementias Completed Phase 2 Trials for Rasagiline (DB01367)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00104273Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)Treatment